Boobalan Pachaiyappan
Stock Analyst at Roth Capital
(0.64)
# 2470
Out of 5,372 analysts
13
Total ratings
45.45%
Success rate
-3.19%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CAPR Capricor Therapeutic... | Reiterates: Buy | 31 31 | 12.21 | 153.89% | 1 | Jun 17, 2025 | |
PYPD PolyPid | Initiates Coverage On: Buy | 9 | 3.51 | 156.41% | 1 | Jun 5, 2025 | |
CING Cingulate | Maintains: Buy | 12 11 | 4.48 | 145.54% | 2 | May 19, 2025 | |
CRVO CervoMed | Maintains: Strong Buy | 15 20 | 7.05 | 183.69% | 3 | Mar 18, 2025 | |
VRNA Verona Pharma | Initiates Coverage On: Buy | 68 | 92.88 | -26.79% | 1 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 7 | 0.72 | 872.22% | 1 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 7 7 | 1.71 | 309.36% | 2 | Dec 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 29 | 7.22 | 301.66% | 1 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 1.23 | 713.01% | 1 | Dec 5, 2024 |